490 related articles for article (PubMed ID: 14988837)
1. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
Sato T; Kanai T; Watanabe M; Sakuraba A; Okamoto S; Nakai T; Okazawa A; Inoue N; Totsuka T; Yamazaki M; Kroczek RA; Fukushima T; Ishii H; Hibi T
Gastroenterology; 2004 Mar; 126(3):829-39. PubMed ID: 14988837
[TBL] [Abstract][Full Text] [Related]
2. Hyperexpression of inducible costimulator on lamina propria mononuclear cells in rat dextran sulfate sodium colitis.
Ishii K; Kanai T; Totsuka T; Uraushihara K; Ishikura T; Yamazaki M; Okamoto R; Araki A; Miyata T; Tezuka K; Nakamura T; Watanabe M
J Gastroenterol Hepatol; 2004 Feb; 19(2):174-81. PubMed ID: 14731127
[TBL] [Abstract][Full Text] [Related]
3. [Expression of co-stimulators in ulcerative colitis and its pathologic significance].
Li F; Chen AJ; Du J; Zhang Y; Gong EC; Shi XY
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):19-24. PubMed ID: 20388394
[TBL] [Abstract][Full Text] [Related]
4. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production.
Liu Z; Geboes K; Colpaert S; D'Haens GR; Rutgeerts P; Ceuppens JL
J Immunol; 2000 Apr; 164(7):3608-15. PubMed ID: 10725717
[TBL] [Abstract][Full Text] [Related]
5. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
6. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
7. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
[TBL] [Abstract][Full Text] [Related]
8. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
[TBL] [Abstract][Full Text] [Related]
9. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
11. Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis.
Totsuka T; Kanai T; Iiyama R; Uraushihara K; Yamazaki M; Okamoto R; Hibi T; Tezuka K; Azuma M; Akiba H; Yagita H; Okumura K; Watanabe M
Gastroenterology; 2003 Feb; 124(2):410-21. PubMed ID: 12557147
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
[TBL] [Abstract][Full Text] [Related]
13. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
14. The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice.
Pfister K; Wittig BM; Jüngling B; Ecker KW; Barth S; Huhn M; Sasse S; Engert A; Mueller-Molaian I; Diehl V; Zeitz M; Stallmach A
Int J Colorectal Dis; 2002 Mar; 17(2):77-84. PubMed ID: 12014425
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation.
Iwai H; Kozono Y; Hirose S; Akiba H; Yagita H; Okumura K; Kohsaka H; Miyasaka N; Azuma M
J Immunol; 2002 Oct; 169(8):4332-9. PubMed ID: 12370365
[TBL] [Abstract][Full Text] [Related]
16. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL
J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009
[TBL] [Abstract][Full Text] [Related]
17. Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease.
Di Sabatino A; Rovedatti L; Kaur R; Spencer JP; Brown JT; Morisset VD; Biancheri P; Leakey NA; Wilde JI; Scott L; Corazza GR; Lee K; Sengupta N; Knowles CH; Gunthorpe MJ; McLean PG; MacDonald TT; Kruidenier L
J Immunol; 2009 Sep; 183(5):3454-62. PubMed ID: 19648266
[TBL] [Abstract][Full Text] [Related]
18. Absence of a role for interleukin-13 in inflammatory bowel disease.
Biancheri P; Di Sabatino A; Ammoscato F; Facciotti F; Caprioli F; Curciarello R; Hoque SS; Ghanbari A; Joe-Njoku I; Giuffrida P; Rovedatti L; Geginat J; Corazza GR; MacDonald TT
Eur J Immunol; 2014 Feb; 44(2):370-85. PubMed ID: 24338958
[TBL] [Abstract][Full Text] [Related]
19. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
[TBL] [Abstract][Full Text] [Related]
20. Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.
Vitale S; Strisciuglio C; Pisapia L; Miele E; Barba P; Vitale A; Cenni S; Bassi V; Maglio M; Del Pozzo G; Troncone R; Staiano A; Gianfrani C
PLoS One; 2017; 12(8):e0182313. PubMed ID: 28797042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
